UPDATE: Piper Jaffray Starts Moderna (MRNA) at Overweight
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $63.02 -0.99%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
(Updated - January 2, 2019 3:30 AM EST)
(updated to correct company name)
Piper Jaffray analyst Edward Tenthoff initiates coverage on Moderna (NASDAQ: MRNA) with a Overweight rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Moderna click here. For more ratings news on Moderna click here.
Shares of Moderna closed at $15.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) Following FDA Approval of mRNA Flu Vaccine
- FDA approves Moderna's mRNA influenza vaccine for adults 50 and older
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper Jaffray, Edward TenthoffSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
